StonvexLoading…
StonvexStonvexStonvexCore line items from ARES's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-07-30 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $1.29B | $1.40B | $5.60B | $4.10B | $2.44B |
Operating Income | Not available | $312.92M | $1.29B | $1.08B | $427.98M |
Net Income | Not available | $142.59M | $527.36M | $473.11M | $184.23M |
EPS (Diluted) | $1.38 | Not available | Not available | Not available | Not available |
Total Assets | Not available | $28.39B | $28.63B | $27.03B | $27.26B |
Total Liabilities | Not available | $20.01B | $19.93B | $18.40B | $18.43B |
Cash & Equivalents | Not available | $568.78M | $488.90M | $496.67M | $509.66M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available | Not available |
Shares Outstanding | Not available | Not available | Not available | Not available | Not available |